EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond resistance: Emerging methods to dissect drug responses in Leishmania

Beatriz Cristina Dias de Oliveira, Jorge Arias Del Angel, Nicole Herrmann May, Michael P Barrett, Malgorzata Anna Domagalska, Tom Beneke iD

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1014331 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Beatriz Cristina Dias de Oliveira und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Developmental Biology, Biocenter, University of Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Leishmania, Drug Resistance, Antiprotozoal Agents, Leishmaniasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, European Molecular Biology Organization, HORIZON EUROPE Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment failure and relapse remain major challenges in leishmaniasis despite available chemotherapies. Historically, these outcomes have been interpreted through the lens of classical drug resistance driven by heritable genetic mutations. However, drug responses are increasingly recognised to extend beyond resistance and include distinct but related phenomena such as hypersensitivity, tolerance, and persistence. Dissecting this range of responses in Leishmania requires approaches that capture both heritable genetic variation and dynamic cellular states. Here, we highlight how emerging genomics and perturb-omics technologies can resolve mechanisms underlying diverse drug responses. We emphasise that their impact depends on state-aware experimental design, including calibrated drug-selection, varied exposure regimens, and strategies to isolate rare persister populations. Together, these approaches provide a framework to move beyond resistance-centric models towards a more comprehensive understanding of parasite drug response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeishmaniaDrug ResistanceAntiprotozoal AgentsLeishmaniasisHumansAnimalsGenomics

Substanzen

Antiprotozoal Agents

Autor:innen und Institutionen

  • Department of Cell and Developmental Biology, Biocenter, University of Würzburg, Würzburg, Germany.
  • School of Infection & Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Experimental Parasitology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

ORCID-Profile: Tom Beneke

Förderung

  • Deutsche Forschungsgemeinschaft
  • European Molecular Biology Organization
  • HORIZON EUROPE Marie Sklodowska-Curie Actions
  • Alexander von Humboldt-Stiftung
  • Biotechnology and Biological Sciences Research Council
  • Department of Work, Economics, Science, Innovation & Social Economics (WEWIS) of the Flemish Government

Zitieren

APA

de Oliveira, B. C. D., Arias Del Angel, J., Herrmann May, N., Barrett, M. P., Domagalska, M. A., & Beneke, T. (2026). Beyond resistance: Emerging methods to dissect drug responses in Leishmania. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014331

Vancouver

de Oliveira BCD, Arias Del Angel J, Herrmann May N, Barrett MP, Domagalska MA, Beneke T. Beyond resistance: Emerging methods to dissect drug responses in Leishmania. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014331

BibTeX
@article{deOliveira2026,
  author = {de Oliveira, Beatriz Cristina Dias and Arias Del Angel, Jorge and Herrmann May, Nicole and Barrett, Michael P and Domagalska, Malgorzata Anna and Beneke, Tom},
  title = {Beyond resistance: Emerging methods to dissect drug responses in Leishmania},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1014331}
}
Kostenlos starten →